Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06217770
Status:
COMPLETED
Last Update Posted:
2024-01-23
First Post:
2024-01-11
Brief Title:
Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment
Sponsor:
Chinese University of Hong Kong
Organization:
Chinese University of Hong Kong
Study Overview
Official Title:
Retrospective Non-interventional Study Assessing the Real-Life Use of The Long- Acting Gonadotropin-releasing Hormone Agonist as A Treatment for Locally Advanced or Meta-static Prostate Cancer in Hong Kong
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
It is a retrospective review of the electronic medical record of patients on long-acting triptorelin in Hong Kong
Detailed Description:
Prostate cancer is the second most prevalent cancer in men worldwide Analogues of natural gonadotrophin releasing hormone GnRH are currently available in clinical practice to induce castration in subjects with prostate cancer While 6 month formulation of Triptorelin has been approved since 2018 for controlling tumor growth in subjects with prostate cancer living in Hong Kong to date there are no published clinical data regarding the use and efficacy of the 6 month formulation in Chinese subjects with Chinese heritage To better understand the real-world experience of long-acting GnRH agonist there is an unmet need for a retrospective noninterventional review to collect data regarding the use of the long-acting formulation GnRH in clinical practice as a treatment for prostate cancer The purpose of this study is to collect data on healthcare characteristics and the treatment patterns in the real-world setting as well as to understand the profile of the subject population using long-acting formulation GnRH agonist
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None